Moderna
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
Beyond's analysis on Moderna
- — Major tech and biotech stocks enter buy zones as broader indices hold steady
- — Suze Orman says a breakup saved an investor more than Moderna's 180% stock surge
- — Moderna's market valuation jumps $30 billion on confidence in its cancer vaccine successes
- — Moderna’s mRNA melanoma vaccine success drives 176% stock jump, validating cancer immunotherapy platform
- — Moderna secures US approval for its first mRNA flu vaccine for adults 50+, overcoming initial Trump administration hesitations
- — Jim Cramer’s renewed endorsement of Moderna signals growing confidence in its mRNA pipeline and potential stock upside
- — US experts endorse Moderna's first mRNA flu vaccine, paving the way for a new mRNA seasonal shot
- — Vespa's 80‑year legacy reshapes modern mobility culture
- — Moderna's profitability question reflects broader market dynamics and investor expectations
Recent news mentioning Moderna
- — Should You Buy Moderna Stock? Why Many Wall Street Analysts Say "No."
- — Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up?
- — AMD, Intel, Meta, Warner Bros., Moderna, Grail, Strategy, and More Stocks That Explain Today’s Market
- — Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.
- — Moderna (MRNA) Soars to Fresh High Ahead of Pipeline Updates This Week
- — Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher
- — Dow Jones Futures: Nasdaq, S&P 500 Hold; Robinhood, Sandisk, AMD, Moderna Surge Into Buy Areas
- — Dow Jones Futures: After S&P 500, Nasdaq Rebound, What's Next? Moderna, AMD, SpaceX Flash Buy Signals.
- — Moderna: Another Day, Another Big Stock Move. Is the Cancer Vaccine Rally Back On?
- — Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
- — Moderna's COVID Vaccine Was a Historic Success. Could Its Cancer Vaccine Be Even Bigger?
- — Dow Jones Futures: Fed Rate Hike Seen As Oil, Yields Pressure Stocks; Apple, Moderna Are New Buys